Clinical trials
Recruiting Phase 1 Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2016 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Benjamin Viglianti | 2 |
| Milton S. Hershey Medical Center | 2 |
| Neurotronic, Inc. | 2 |
| BRAC University | 1 |
| D. Walter Wray | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| Korea United Pharm. Inc. | 1 |
| Monash University | 1 |
| National Institute of Cardiology, Laranjeiras, Brazil | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 21 |
| Obesity | 4 |
| Diabetes Mellitus | 3 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Atherosclerosis | 1 |
| Dyslipidemias | 1 |
| Essential Hypertension | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Heart Failure | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.